Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa

Clinical trial NCT07482787 · RECRUITING

Trial details

NCT number: NCT07482787
Sponsor: Paradigm Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Epidermolysis Bullosa (EB)

Start date: 2026-07-21
Primary completion: 2027-05-17
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.